Bed nucleus of the stria terminalis regulates fear to unpredictable threat signals
- Texas A&M University, United States
Figures
Figure 1 with 5 supplements
Reversible inactivation of the BNST attenuates conditioned fear expression to a backward, but not forward, CS.
(A) Behavioral schematic. (B) Freezing behavior at conditioning and retrieval testing. For conditioning, the left panel depicts mean percentage freezing during the 5 min baseline (BL) and across each conditioning block (each 136 s block is comprised of two trials; conditioning trials consist of freezing during the 10 s CS followed by the 58 s interstimulus interval). For retrieval testing, the center panel shows mean percentage freezing at the 5 min baseline (BL) and across each test block (each 140 s block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 60 s interstimulus interval). The right panel shows mean percentage freezing during the first half of the test (trials 1–6; corresponding to 420 s of behavior). All data are represented as means ± s.e.m [FW-VEH (n = 5); FW-NBQX (n = 4); BW-VEH (n = 13); BW-NBQX (n = 12); NoCS(Test)-VEH (n = 8); NoCS(Test)-NBQX (n = 8)]; * = p < 0.05.
-
Figure 1—source data 1
- https://doi.org/10.7554/eLife.46525.008
Figure 1—figure supplement 1
Representative bilateral cannula placements in the BNST.
Photomicrograph (10×) of a thionin-stained coronal section depicting representative cannula tracts in the BNST (top panel). Fluorescent image (gold filter) of a coronal section (10×) showing spread of drug in BNST (BNST outlined in dotted line) (bottom panel).
Figure 1—figure supplement 2
Bilateral cannula placements for BNST microinfusions.
Schematic depicting cannula placements for Figure 1. Symbols (split by each group) correspond to injector tips (approximate borders of BNST are shown by red dotted outline; approximate borders of BNST are shown by red dotted outline).
Figure 1—figure supplement 3
Effects of BNST inactivation on freezing to a forward vs. backward CS trained with five trials.
(A) Behavioral schematic. (B) Freezing behavior during conditioning and retrieval testing. For conditioning, the left panel depicts mean percentage freezing during the 3 min baseline (BL) and across each conditioning block (each 136 s block is comprised of two trials; conditioning trials consist of freezing during the 10 s CS followed by the 58 s interstimulus interval). For retrieval testing, the center panel shows mean percentage freezing at the 3 min baseline (BL) and across each test trial (each trial consists of freezing during the 10 s CS followed by the 60 s interstimulus interval). The right panel shows mean percentage freezing after baseline (trials 1–5; corresponding to 350 s of behavior). All data are represented as means ± s.e.m [FW-VEH (n = 6); FW-NBQX (n = 6); BW-VEH (n = 7); BW-NBQX (n = 6)]; * = p < 0.05.
Figure 1—figure supplement 4
Bilateral cannula placements for BNST microinfusions.
Schematic depicting cannula placements for Figure 1—figure supplement 3. Symbols (split by each group) correspond to injector tips (approximate borders of BNST are shown by red dotted outline).
Figure 1—figure supplement 5
Shock-induced activity during conditioning to a forward vs. backward CS.
(A) Mean percentage of freezing at baseline (BL; 5 min) and across conditioning blocks (each 136 s block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 58 s interstimulus interval). (B) Mean activity values across the 5 min BL (no shock present). (C) The left panel shows mean shock-induced activity (during shocks) at conditioning [averaged into 4 s (two-shock) blocks]. The right panel shows mean shock-induced activity across all trials. All data are represented as means ± s.e.m [FW (n = 16); BW (n = 16)]; * = p < 0.05.
Figure 2 with 1 supplement
BNST inactivation attenuates freezing to a discrete CS paired with random onset of shock.
(A) Behavioral schematic. (B) Freezing behavior during conditioning and retrieval testing. For conditioning, the left panel depicts mean percentage freezing during the 5 min baseline (BL) and across each conditioning block (each block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 58 s interval for the BW animals, whereas blocks for the other groups include equivalent time periods which include the CS [if present] and inter-CS intervals [excluding the duration of the shock]). For retrieval testing, the center panel shows mean percentage freezing at the 5 min baseline (BL) and across each test block (each 140 s block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 60 s interval). The right panel shows mean percentage freezing across the first two test trials (after BL; corresponding to 140 s of behavior). All data are represented as means ± s.e.m [RANDOM-VEH (n = 6); RANDOM-MUS (n = 9); BW-VEH (n = 5); BW-MUS (n = 7); NoCS(Cond)-VEH (n = 7); NoCS(Cond)-VEH (n = 6)]; * = p < 0.05.
-
Figure 2—source data 1
- https://doi.org/10.7554/eLife.46525.011
Figure 2—figure supplement 1
Bilateral cannula placements for BNST microinfusions.
Schematic depicting cannula placements for Figure 2. Symbols (split by each group) correspond to injector tips (approximate borders of BNST are shown by red dotted outline).
Figure 3 with 1 supplement
Temporary inactivation of the BNST does not prevent conditioned fear expression to a forward CS paired with a US of fixed or variable intensity.
(A) Behavioral schematic. (B) Freezing behavior during conditioning and retrieval testing. For conditioning, the left panel depicts mean percentage freezing during the 5 min baseline (BL) and across each conditioning block (each 136 s block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 58 s post-shock interval). For retrieval testing, the center panel shows mean percentage freezing at the 5 min baseline (BL) and across each test block (each 140 s block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 60 s interval). The right panel shows mean percentage freezing across all test trials (after BL; corresponding to 840 s of behavior). (C) Freezing percentages across all twelve trials, with BL levels of freezing subtracted from these values. All data are represented as means ± s.e.m [FIXED-VEH (n = 7); FIXED-MUS (n = 8); VARIABLE-VEH (n = 7); VARIABLE-MUS (n = 8)].
-
Figure 3—source data 1
- https://doi.org/10.7554/eLife.46525.014
Figure 3—figure supplement 1
Bilateral cannula placements for BNST microinfusions.
Schematic depicting cannula placements for Figure 3. Symbols (split by each group) correspond to injector tips (approximate borders of BNST are shown by red dotted outline).
Figure 4
CS-evoked freezing in rats utilized for Fos analyses.
(A) Behavioral schematic. (B) Freezing during conditioning and retrieval testing. For conditioning, the left panel depicts mean percentage freezing during the 5 min baseline (BL) and across each conditioning block (each 136 s block is comprised of two trials; conditioning trials consist of freezing during the 10 s CS followed by the 58 s interstimulus interval). For retrieval testing, the center panel shows mean percentage freezing at the 5 min baseline (BL) and across each test block (each 140 s block is comprised of two trials; trials consist of freezing during the 10 s CS followed by the 60 s interval). The right panel shows mean percentage freezing after BL (corresponding to 840 s of behavior). Animals were sacrificed for Fos analyses 90 min after trial 1. All data are represented as means ± s.e.m [FW (n = 8); BW (n = 14); NoCS(Test) (n = 17); NoTest (n = 8)]; * = p < 0.05.
-
Figure 4—source data 1
- https://doi.org/10.7554/eLife.46525.016
Figure 5
Fos expression in the BNST following exposure to a temporally predictable or uncertain CS.
(A) Schematic depicting regions counted within the BNST (left panel). The right panel shows example of Fos expression in the ventral BNST (vBNST). (B) Mean Fos-positive cells per 0.1 mm2 for each of the quantified regions. All data are represented as means ± s.e.m [FW (n = 8); BW (n = 14); NoCS(Test) (n = 17); NoTest (n = 8)]; * = p < 0.05.
-
Figure 5—source data 1
- https://doi.org/10.7554/eLife.46525.018
Figure 6 with 1 supplement
Functional tracing in afferents targeting the BNST.
(A) Coronal section (10×) showing representative fluorescence of a CTb infusion (green) into the BNST (dotted outline; ‘ac’=anterior commissure, ‘lv’=lateral ventricle). Black ‘X’ denotes approximate lowest point of the infusion (as an example of how injection sites are documented in Figure 6—figure supplement 1). (B) Coronal schematic (−0.26 mm from bregma) showing the approximate largest (green) and smallest (dark green) areas of CTb spread in the BNST for animals included in the analyses; the black dotted outline represents the extent of spread of CTb in the BNST in the image shown in panel A. (C) Example CTb-positive (green) and Fos-positive (red; nuclei) cells in a coronal section (40 μm) of the IL; open white squares denote double-labeled cells. (D) Mean number of BNST-targeting CTb-positive cells (per 0.1 mm2) for each of the quantified regions (shows FW, BW, and NoTest animals corresponding to Figure 7). All data are represented as means ± s.e.m (for each region, n = 30); * = p < 0.05.
-
Figure 6—source data 1
- https://doi.org/10.7554/eLife.46525.021
Figure 6—figure supplement 1
CTb injection sites in BNST.
Approximation of the most ventral and centermost sites of unilateral microinjection of CTb (green X’s) for all animals shown in Figures 6 and 7 (red outline approximates borders of BNST).
Figure 7
Fos expression in BNST-targeting cells of the prefrontal cortex, amygdala, and hippocampus following exposure to a forward or backward CS.
(A) Mean number of Fos-positive cells (per 0.1 mm2) for each of the quantified regions. (B) Mean percentage (per 0.1 mm2) of Fos-positive and CTb-positive cells divided by the total number of CTb-positive cells for each region. All data are represented as means ± s.e.m [FW (n = 8); BW (n = 14); NoTest (n = 8)]; * = p < 0.05.
-
Figure 7—source data 1
- https://doi.org/10.7554/eLife.46525.023
Additional files
-
Transparent reporting form
- https://doi.org/10.7554/eLife.46525.024
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Bed nucleus of the stria terminalis regulates fear to unpredictable threat signals
eLife 8:e46525.
https://doi.org/10.7554/eLife.46525
